The literature evidencing the role of iron in promoting a range of neoplasms in humans and animals prompted us to search for a possible association between chemically induced hemosiderosis and hemangiosarcomas in the liver of mice in selected studies conducted by the National Toxicology Program (NTP). Its historical control database was examined for studies in which treatment-related liver hemangiosarcoma was noted; 130 consecutive NTP studies in B6C3FI mice from Technical Report (TR)-340 to TR-493 were evaluated. Three compounds (2-butoxyethanol, p-nitroaniline. and para-chloroaniline) were associated with a relatively high incidence of Kupffer cell pigmentation consisting of hemosiderin in both sexes; only the male mice developed a relatively low incidence of treatment-related hemangiosarcoma. With a fourth compound (o-nitroanisole), a relatively low incidence (16/50, high-dose males) of chemical-related hemosiderosis was noted, with no associated increase of hemangiosarcoma. Two chemicals (pentachlorophenol and tetrafluoroethylene) increased the incidence of liver hemangiosarcoma in male and female mice. with no increase in Kupffer cell pigmentation. The overall association between liver hemangiosarcoma and Kupffer cell pigmentation was highly significant (p < 0.001). The cause for hemosiderosis in all cases was the erythrocytic hemolytic effect of the compounds. The reason for the sex-increased susceptibility for development of hemangiosarcoma is unknown but may be due to a hormone-related. reduced antioxidative defensive capacity through modulation of the activities of antioxidative enzymes.
INTRODUCTION
Iron is an essential metal involved in oxygen transport by hemoglobin in mammals and the activity of a variety of enzymes. Deficiency in iron may lead to a state of anemia, while an excess may promote oxidative damage to tissues (Toyokuni, 2002) . Oxidative damage to DNA may lead to errors in genomic information. Reactive oxygen species (ROS) can interact with DNA and cause several types of damage: modification of DNA bases, single-and double-DNA breaks, loss of purines (apurinic sites), damage to the deoxyribose sugar, DNA-protein cross-linkage, and damage to the DNA repair system (Kohen and Nyska, 2002) .
Numerous reports suggest an association between increased body iron stores and higher risk of cancer, both in human and animals (Fracanzani et al., 2001; Weinberg, 1983; Rubin and Farber, 1988) . The iron overload may be iatrogenic via injection, inhalation, ingestion, or pathologic processes, like hereditary hemochromatosis and certain anemias, such as thalassemia major. Results of epidemiological studies have been generally consistent with the hypothesis that increased available body-iron stores increase the risk of cancer or general mortality (Stevens et al., 1994) . Patients with hereditary hemochromatosis (HC) were reported to be at high risk of both liver cancer and other malignancies (Fracanzani et al., 2001) . Hepatocellular carcinoma is considered to be one of the two major causes of death in HC patients; the other is hepatic failure with cirrhosis. A case of hepatic Kupffer-cell sarcoma was also described in HC (Kwittken and Tartow, 1966) . In humans iron may influence the risk for some cancers and not others (Stevens et al., 1988 (Stevens et al., , 1994 . For example, cancer of the stomach in men appeared to be unrelated to markers of iron statusserum levels of ferritin and transferrin, while the opposite correlation was seen for cancer in the colon, bladder, esophagus, and lungs. In an epidemiologic study in which indirect measures of body-iron stores-anemia and total iron-binding capacity (TIBC) of plasma-were tested for potential risk of lung cancer, relatively low TIBC and anemia (hemoglobin less than 12 g) were shown to be associated with low risk of lung cancer in women, but not in men (Selby and Friedman 1988) . ' In thalassemia, the sources of excess iron are the patient's diet, transfused blood, and release of iron by intravascular hemolysis. Investigating the cause of death in thalassemia major patients, researchers found that 8 of 96 patients had cancer, of whom 5 had leukemia or lymphoma. Iron was suggested to be one of the potential carcinogenic factors in these cases (Zurlo et al., 1989) . Risk of liver cancer development was also suggested in persons suffering from thalassemia (Shuangshoti and Thaicharoen, 1994) . Increased risk for osteogenic sarcoma development was reported in a patient suffering from Diamond-Blackfan anemia (Lipton et al., 2001) a rare congenital, purely red-cell, aplasia. A moderate to seṽ ere aregenerative anemia is found in association with erythroblastopenia in an otherwise normocellular bone marrow (Da Costa et al., 2001) . One cause of hemosiderosis is iron overload resulting from blood transfusion, believed to be one of the factors contributing to development of malignancy in these patients (Janov et al., 1996) . Richmond (1959) demonstrated sarcoma induction at the site of injection following long-term injection ofiron dextran. The latent period of 10 to 14 months was noted in adult rats, and 9-months' latency was noted in young rats. The data suggested that the tumors arose from histiocytes accumulating iron at the site ofthe injection The accumulation of ceroid pigment in addition to hemosiderin by the histiocytes indicated deficiency of the antioxidant vitamin E. These findings were confirmed and extended by Haddow (1960) . In this study sarcomas developed at the site of injection 11 months into the experiment following a 13-week period of weekly subcutaneous injections of 0.2 ml of Imferon (equivalent to 10 mg Fe). Both the phagocytic cells of the tumor, and many of the malignant cells themselves, contained a pigment resembling hemosiderin (Prussian-blue positive). An additional experiment using higher doses of this compound suggested that "larger and more protracted dosage materially accelerated tumor emergence." Hamsters were generally refractory to the injection of this compound, as only one out of 20 exposed animals developed sarcoma; no tumors were recorded in a second experiment in which 30 hamsters were similarly treated (Haddow, 1960) .
Hemosiderin, golden-yellow to brown and granular or crystalline, is the insoluble form of complexed iron-protein and a hemoglobin-derived, degradative product of red cells. Under normal conditions iron is stored associated with protein within cells, forming ferritin, a soluble form of ironprotein complex. When there is a local or systemic excess of iron, referred to as primary or secondary overload, ferritin forms hemosiderin granules. The liver reticuloendothelial system and intestinal mucosa are the most significant metabolic storage sites in cases of excessive iron overload (Black, 1981) . Kupffer cells, resident macrophages in the liver, constitute the largest macrophage population in the body, representing approximately 80-90% of all fixed macrophages, and compose approximately 15% of the total number of cells in the liver (Boelsterli, 2003) .
The role of iron in the promotion of a range of neoplasms prompted us to examine the possible association between chemically induced hemosiderosis and hemangiosarcomas in mouse liver, in selected studies conducted by the National Toxicology Program (NTP).
MATERIALS AND METHODS

Source of Data
The NTP historical control database was searched for studies in which treatment-related liver hemangiosarcoma, as well as treatment-related liver Kupffer cell pigmentation, were noted. For the purpose of this retrospective investigation, the evaluation of a total of 130 consecutive NTP studies in B6C3Fl mice from TR-340 to TR-493 was conducted. The data were derived from 2-year carcinogenicity studies in which the B6C3F1 mice were approximately 6 weeks old at study start. Over the past 30 years, the NTP and National Cancer Institute (NCI) have conducted more than 500 long-term rodent carcinogenicity studies. Although our review was limited to 130 recent NTP studies, it included all but one chemical (nitrofen) producing liver hemangiosarcoma in B6C3F1 mice in the >500-chemical NTPINCI database. While the nitrofen study conducted more than 25 years ago was excluded from our investigation because it was so old that slides were no longer available for reexamination, the original report from that study revealed no treatment-related Kupffer cell pigmentation in mice (NCI, 1978) .
Histopathology
The diagnoses of pathologies in NTP studies are subjected to a rigorous peer review to assure accuracy and consistency of the identification of both neoplastic and nonneoplastic lesions within a study. Similarly, there is an effort to assure consistency in the diagnostic approach for neoplastic lesions across NTP studies. For the purpose ofthis retrospective evaluation, all cases of liver hemangiosarcoma were rechecked, and the original diagnosis was reconfirmed by one pathologist. When there was any disagreement with the original diagnosis, any case in question was presented to two other pathologists, and a consensus was achieved. Criteria used to diagnose hemangiosarcoma were those commonly accepted by toxicological pathologists (Ernst et al., 2001) . All studies were reviewed for the presence or absence of treatmentrelated pigment deposits in the liver sections. Reevaluation of the slides did not reveal any disagreement.
Information identifying the nature of the deposited pigment using specific histochemical staining (Prussian-blue for iron, Hall method for bile) was derived from the technical reports. No attempt was made to quantify the pigmentation or to verify if the pigment involved types of cells besides Kupffer cells, such as hepatocytes or endothelial, bile-duct epithelial, or portal-tract stromal cells. In addition, liver sections from animals treated with the same compounds derived from preliminary studies (e.g., 14 days or 3 months) were not reevaluated. In none ofthe technical reports ofthe compounds in which treatment-related hemangiosarcoma were observed was there any mention of potential pre-neoplastic changes in the liver. Liver hemangiosarcoma is a relatively uncommon neoplasm in B6C3F1 mice, occurring at a spontaneous rate of 2.6% (35/1350; range 0-6%) in untreated males and 0.6% (8/1350; range 0-2%) in untreated females (Haseman et al., 1998) . Kupffer cell pigmentation is not commonly recorded as being present in mouse liver in the 2-year NTP studies, and no definitive historical control database exists for the lesion.
Statistical Evaluation
The overall association between liver hemangiosarcoma and Kupffer cell pigmentation was tested using the Fisher's exact test (Armitage, 1971) .
RESULTS
Out of a total of 130 studies reviewed, no liver hemangiosarcoma and no Kupffer cell pigmentation occurred in 120. The other 10 studies showing increased incidence of liver hemangiosarcoma and/or Kupffer cell pigmentation are presented comprehensively in Table 1 .The original diagnoses of hemangiosarcoma were confirmed, and the nature of pigmentation is presented.
The association between Kupffer cell pigmentation and liver hemangiosarcoma is summarized in Table 2 . In 3 of the 8 compounds in which Kupffer cell pigmentation was noted, TABLE I.-Chemicals tested for carcinogenicity in 2-year mouse studies at the NTP, with incidence of either liver hemangiosarcoma and/or Kupffer cell pigmentation and nature of accumulated pigment. the reasons for this change were other than hemosiderosis (see Table 1 ). Similarly, 1 (pentachloroanisole) of the 4 chemicals that induced both Kupffer cell pigmentation and hemangiosarcoma exhibited pigmention of an unknown nature. In all studies mentioned in Table 1 in which increased hemangiosarcoma was noted, the treatment-related hemangiosarcoma developed only in the liver, except in the case of parachloroaniline, in which hemangiosarcomas were seen also in the spleen. No increase in hemosiderin pigmentation was noted in the spleen. When the studies showing Kupffer cell pigmentation related to hemosiderosis were evaluated, the overall association between liver hemangiosarcoma and Kupffer cell pigmentation was highly significant (p < 0.001) by Fisher's exact test (Armitage, 1971) with an overall concordance of 97% (126/130; see Table 2 ). Thus, in B6C3FI mice, a chemical associated with Kupffer cell pigmentation related to hemosiderosis has a high likelihood (3/4 or 75%) of producing liver hemangiosarcoma, compared with a very low likelihood (3/126or 2%) in the absence of such pigmentation.
Incidence of liver
This retrospective evaluation revealed 3 compounds (2-butoxyethanol, p-nitroaniline, and para-chloroaniline) in which a relatively high incidence (60-100% in the'high-dose) of Kupffer cell pigmentation consisting of hemosiderin was noted in both sexes; with these, only male mice developed a relatively low incidence of treatment-related hemangiosarcoma (Table I) . For the 2-butoxyethanol study, the NTP report (2000) concluded that there was some evidence of carcinogenic activity in male B6C3Fl mice based on increased incidences of hemangiosarcdrna of the liver. An increased incidence of hemosiderosis was seen in both sexes in the liver and spleen. For the p-nitroaniline study, the NTP report (1993D) concluded that there was equivocal evidence of carcinogenic activity in male B6C3Fl mice based on the increased incidences of hemangiosarcoma of the liver and combined hemangioma or hemangiosarcoma at all sites. An increased incidence of hemosiderosis was seen in both sexes in liver and spleen. In the assessment of para-chloroaniline, the NTP technical report concluded that there was some evidence of carcinogenic activity in male B6C3Fl mice, indicated by increased incidences of hepatocellular neoplasms (carcinomas) and hemangiosarcomas, nearly all in the liver or spleen (NTP, 1989B) . The technical report stated that "1 vehicle control male mouse and 3 high-dose male mice had liver neoplasms with characteristics of hepatocellular carcinomas but which also contained vascular elements similar to those of hemangiosarcomas; both hepatocellular carcinomas and hepatic hemangiosarcomas were diagnosed in each of these animals." Increased hemosiderin pigmentation was seen only in the liver. Table 1 emerged following examination of the possible association between chemically induced hemosiderosis and hemangiosarcomas in mouse liver, in selected studies conducted by the NTP. For three compounds associated with increased incidences of Kupffer cell pigmentation related to hemosiderosis, treatment-related increase in hemangiosarcoma was noted in the liver. With a fourth compound, o-nitroanisole, only in 16/50 of the high-dose males was chemically related hepatic hemosiderosis noted, but no associated increased incidence of hemangiosarcoma was observed. The increase in hepatic hemangiosarcomas was relatively small in the 3 studies in which association was noted; this association existed for male mice only. The only 2 chemicals-pentachlorophenol and tetrafluoroethyleneproducing liver hemangiosarcoma in female mice induced no Kupffer cell pigmentation, Although these 4 compounds (2-butoxyethanol, p-nitroaniline, para-chloroaniline, and o-nitroanisole) induced hemangiosarcomas in mouse liver, none of them induced the same tumor in the liver of rats, as indicated in other NTP investigations. No common chemical structural similarities were found among the three compounds in which association of hemosiderosis and hemangiosarcoma was noted; therefore, another ;common pathological mechanism involving hemolysis and hemosiderosis is suggested.
DISCUSSION
Important results summarized in
Suggested mechanisms for the role of iron in tumor promotion (Toyokuni, 1996) include its involvement in the production of reactive oxygen species (ROS), its suppression of the tumoricidal functioning of macrophages, and its facilitation of proliferation of certain cells. These mechanisms may function individually andlor by some degree of combined action.
Iron, whichis known to be a potent pro-oxidant, catalyzes the production of ROS derived from Kupffer cell activation or other biological processes via the metal-mediated Haber-Weiss reaction (Kakhlon and Cabantchik, 2002) This production may lead to two possible consequences. One is redox regulation failure that leads to oxidative damage to lipids, protein, and DNA. Damage to the latter may consist of a point mutation, a deletion, an addition, or a chromosomal translocation which may, in turn, promote mutation and tumor initiation (Welch et al., 2002) . These events may cause activation of proto-oncogenes or inactivation of tumor suppressor genes, such as p 16 (Toyokuni, 2002) . The other consequence is redox regulation with activation of a variety of reducing, enzymatic, and non-enzymatic oxystress-protective mechanisms, as well as activation of signal transduction pathways, such as those involving growth factors such as TNF-alpha 226 NYSKAET AL. TOXICOLOGIC PATHOLOGY and hormones; both activations can lead to tumor promotion. Activation of proto-oncogenes (e.g., AP-J, myc) or disruption of apoptosis regulators (e.g., Bcl-2) can stimulate cellular proliferation or inhibit apoptosis (Manna and Aggarwal, 1999; Rose et al., 1997) . Oxidation-specific epitopes can be detected within and around iron-containing cells.
Immunosuppression is another mechanism by which iron may playa role in tumor promotion. The tumoricidal action of macrophages was found to be suppressed by phagocytosed erythrocytes, erythrocytic lysate, hemoglobin, iron salts, or iron dextran (Weinberg and Hibbs, 1977) .
Facilitation of tumor growth has been demonstrated in experiments suggesting that iron is involved in the control of the proliferation of various types of cells and that the use of iron chelators may play a role in preventing the growth of these cells (Le and Richardson, 2002; Porreca et al., 1994; Rakba et al., 2000) . Different types of experimental carcinogenesis models have been utilized to demonstrate that iron nutrition of the host affects tumor growth, for tumor cells grow better in an iron-rich environment (Hann et al., 1988) .
The reason for hemosiderosis in all cases examined in our retrospective analysis was the hemolytic effect of the compounds (NTP, 1989B, 1993C, 1993D, 2000 . The reason for the sex-increased susceptibility for development of hemangiosarcoma is unknown but may be due to a hormonerelated, reduced antioxidative defensive capacity through modulation of the activities of the anti oxidative enzymes. In a hormone-induced prostatic cancer rat model, androgens and estrogens induced a lobe-specific shift in the prooxidantantioxidant balance and alterations in antioxidant enzyme activities leading to oxidative stress in vivo (Tam et al., 2003) . Estrogens were shown to be neuroprotective and cardiovascular-protective through their antioxidative capacity; the liver was protected from the oxidative damage induced by tert-butyl hydroperoxide through the action of estrogens (Behl et al., 1997; Leal et al., 1998; Sack et al., 1994) .
2-Butoxyethanol (BE), via the action of 2-butoxyacetic acid, induced hemolysis in rats and mice (Ghanayem and Sullivan, 1993) . 2-Butoxyethanol and 2-butoxyacetic acid, examined in a number of test systems, have not been demonstrated to be mutagenic or directly genotoxic in vivo and in vitro (Elliot and Ashby, 1997) . Similarly, investigators recently reported that BE and 2-butoxyacetic acid failed to induce transformation in the Syrian hamster embryo (SHE) cell transformation model (Park et al., 2002) . The mechanisms involved in BE-induced neoplasia are not known; however, indirect or epigenetic mechanisms are apparently involved. Investigating possible mechanisms of hemangiosarcoma induction in mice by BE, Siesky et al. (2002) proposed that the induction of neoplasia by BE occurs indirectly through the induction of oxidative stress, oxidative stress in turn was followed by increased oxidative damage and DNA synthesis, driven by iron deposition in Kupffer cells from red blood cell hemolysis. A biphasic increase in oxidative damage, indicated by increased levels of 8-hydroxydeoxyguanosine and malondialdehyde, and increased DNA synthesis were seen in mouse liver after 7 and 90 days of treatment with BE, whereas no increases were observed in treated rat liver. Both strains were treated with BE, administered daily by gavage, 5 times per week, at doses of 0, 225,450, and 900 mglkg/day (mice) and 0, 225, and 450 mglkg/day (rats). According to Siesky et al, (2002) , the species selectivity (i.e., mice, not rats) for the induction of oxidative stress by BE may be explained in part by differences in antioxidant levels between these rodents. Although BE treatment reduced vitamin E levels in both rat and mouse liver, the basal level was approximately 2.5-fold higher in the rat. The data from these studies suggest that the lack of tumor induction by BE in the rat liver was a result of the substantially greater vitamin E content present over that in the equivalent mouse tissue.
Another example of hemolysis-related specific oxidative stress in the liver was reported in the case of subchronic treatment of rats with phenylhydrazine, which led to marked anemia and methemoglobinemia (Comporti et al., 2002) . A striking increase (more than 7-fold) in nonprotein-bound desferrioxamine-a chelatable form of iron (DCI)-and in ferritin occurred in the liver. That such a massive presence of DCI could induce oxidative reactions in the liver was suggested. The marked fragmentation of the DNA from the liver of phenylhydrazine-treated animals indicated the reaction of redox active iron with the DNA.
The association of chemically related hemosiderosis and cancer due to direct iron overload or secondary to hemolytic anemia was reported in laboratory animals. In the case of aniline and several structurally related aromatic amines, like para-chloroaniline, known to lack genotoxic potential, the pathogenesis of splenic.sarcoma seen in male F344/N rats was suggested to be related to increased hemosiderin deposits in this organ (Bus and Popp, 1987) . Male rats treated for 2 years with N,N-dimethylaniline developed dose-related increased severity of splenic hemosiderosis, which was associated with 4/50 (8%) of the cases of splenic sarcoma, while no such case was noted in the controls (NTP, 1989B) . The effects of aniline were mainly restricted to the male rat. In no case were similar splenic changes noted in mice exposed to the same compounds. Pathologically, the tumors noted with this group of compounds consisted of fibrosarcomas, hemangiopericytomas, and hemangiosarcomas, as well as nonneoplastic changes, such as capsular and parenchymal fibrosis, suggested to be preneoplastic (Goodman et al., 1984; Weinberger et al., 1985) .
Analysis of splenic histological sections from an anilineexposure study indicated dose response in the accumulation of hemosiderin. Aniline was shown to be hematotoxic. That the splenic toxicity was related to the major splenic function of removal of aged or damaged erythrocytes, coupled with the potential enhanced delivery of toxic metabolites carried to the spleen in the scavenged red blood cells, was suggested (Goodman et al., 1984) . The aniline metabolite may have then bound to critical macromolecules in the spleen, or the tissue damage may have been mediated by iron-catalyzed free-radical reactions. Another suggestion postulated that the events leading to the carcinogenicity of aniline are thresholdspecific and not set into motion until the ability of the red blood cell to cope with the toxic insult is exceeded (Bus and Popp, 1987) . As a further example of a compound perturbing iron homeostasis, administration of ferric nitrilotriacetate to male Wistar rats induced a significant (54.8%) development of renal hemosiderosis and an associated increased incidence (25%) of renal cell carcinoma .
In conclusion, the present retrospective evaluation of 130 two-year carcinogenicity studies conducted in B6C3FI mice at the NTP indicated that an overall association between liver hemangiosarcoma and Kupffer cell pigmentation was highly significant (p < 0.001) and limited to males. Although a comparable incidence of hemosiderosis was noted in the females, no development of any treatment-related tumor in this organ was noted. The hemosiderosis was related to the hemolytic effect of these compounds. The data suggest that a significantly increased risk of inducing hepatic hemangiosarcomas in the male B6C3Fl mouse exists in studies with chemicals that cause increased tissue burdens of ROS.
